Neurocrine Biosciences
NBIX
#1395
Rank
$15.23 B
Marketcap
$152.79
Share price
-1.27%
Change (1 day)
14.84%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company